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Abstract
Mitochondrial DNA (mtDNA) is particularly susceptible to oxidative damage and mutation due to the high rate of reactive
oxygen species (ROS) production and limited DNA-repair capacity in mitochondrial. Previous studies demonstrated that the
increased mtDNA copy number for compensation for damage, which was associated with cigarette smoking, has been
found to be associated with lung cancer risk among heavy smokers. Given that the common and ‘‘non-pathological’’ mtDNA
variations determine differences in oxidative phosphorylation performance and ROS production, an important determinant
of lung cancer risk, we hypothesize that the mtDNA variations may play roles in lung cancer risk. To test this hypothesis, we
conducted a case-control study to compare the frequencies of mtDNA haplogroups and an 822 bp mtDNA deletion
between 422 lung cancer patients and 504 controls. Multivariate logistic regression analysis revealed that haplogroups D
and F were related to individual lung cancer resistance (OR=0.465, 95%CI=0.329–0.656, p,0.001; and OR=0.622,
95%CI=0.425–0.909, p=0.014, respectively), while haplogroups G and M7 might be risk factors for lung cancer (OR=3.924,
95%CI=1.757–6.689, p,0.001; and OR=2.037, 95%CI=1.253–3.312, p=0.004, respectively). Additionally, multivariate
logistic regression analysis revealed that cigarette smoking was a risk factor for the 822 bp mtDNA deletion. Furthermore,
the increased frequencies of the mtDNA deletion in male cigarette smoking subjects of combined cases and controls with
haplogroup D indicated that the haplogroup D might be susceptible to DNA damage from external ROS caused by heavy
cigarette smoking.
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Introduction
Lung cancer has replaced liver cancer to become the leading
cause of cancer-related deaths in China, accounting for 22.7% of
all cancer deaths [1]. The rates of morbidity and mortality
continue to rise rapidly and the lung cancer patients will reach one
million in 2025 if no effective control measures were taken [2].
Cigarette smoking and asbestos are the two major causes of lung
cancer, however, not all of those who have been exposed to the
risk factors will develop lung cancer, suggesting that other causes,
including genetic susceptibility, might contribute to the individual
lung cancer risk and that gene-environment interactions may exist
[3–5].
Until now, many studies have been focused on the genetic
variants of nuclear genomic DNA encoding genes to investigate
the gene–environment interaction of genetic variants of genes with
lung cancer risk and found that several polymorphisms of genes
such as CYP2E1, CYP1A1, XRCC1, and others are associated
with lung cancer risk [6–9]. However, very few studies have
investigated the role of mitochondrial DNA (mtDNA) variations in
individual susceptibility to lung cancer. Through the Krebs cycle
and oxidative phosphorylation (OXPHOS), mitochondria produce
both ATP to help cells survive and approximately 85% of
intracellular reactive oxygen species (ROS), which can promote
cellular differentiation or induce apoptosis. Human mtDNA is a
circular molecule of approximately 16.5 kb, encoding 22 transfer
RNAs (tRNAs), 2 ribosomal RNAs (rRNAs) and 13 respiratory
chain subunits that are essential for the respiratory functions of the
mitochondria [10,11]. Prior studies have demonstrated that some
mtDNA haplogroups are associated with human susceptibility to
metabolic and degenerative diseases, and influence longevity and
carcinogenesis in conditions where mitochondrial ROS produc-
tion is thought to play a role [12–15]. In addition, the common
and ‘‘non-pathological’’ mtDNA variations that define mtDNA
haplogroups have been found to determine differences in
OXPHOS performance and ROS production in mice and
humans [16–19].
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oxidative damage and mutation due to the high rate of ROS
production and limited DNA-repair capacity in mitochondria
[20,21]. Cigarette smoking is one exposure that induces oxidative
stress by creating ROS within the human body [22,23]. Chronic
oxidative stress may induce mtDNA damage, leading to point
mutations, insertions or deletions [24,25]. The accumulation of
oxidative damage and the resulting sequence variations in mtDNA
may ultimately lead to abnormal OXPHOS in affected cells,
which may play a role in the occurrence of mitochondrial-related
diseases. Recently, the increased mtDNA copy number for
compensation for damage has been found to be positively
associated with subsequent lung cancer risk among heavy smokers
[26].
Given that the common and ‘‘non-pathological’’ mtDNA
variations that define an mtDNA haplogroup contribute to
differences in OXPHOS performance and intracellular ROS
production and that the level of ROS present is an important
determinant of cancer risk, we hypothesize that the mtDNA
variations defining some mtDNA haplogroups may play a role in
susceptibility to lung cancer. To test this hypothesis, a case-control
study was conducted to investigate the role of mtDNA variation in
lung cancer risk in a Han Chinese population from southwestern
China. In addition, the gene-environment interactions between
the mtDNA variations and cumulative cigarette smoking were
analyzed.
Materials and Methods
Study group
Patients (n=442) with primary lung cancer diagnosed from
September 2007 to December 2008 were recruited from the
Institute of Human Respiratory Disease of Xinqiao Hospital. All
patients were newly diagnosed, histologically confirmed and
previously untreated. 504 age and sex-matched control samples
were collected from individuals at the Center of Physical
Examination of Xinqiao Hospital between November 2007 and
December 2008. The exclusion criterion for the control group was
any history of cancer. All of the subjects were unrelated at least
within three generations. After explaining the purpose and
procedures of the study, all participants signed a written informed
consent form and completed a detailed questionnaire regarding
their smoking habits. Blood samples were drawn into Na-EDTA
tubes from all subjects and stored at 270uC for genomic DNA
extraction. The study was approved by the Ethical Committee of
Xinqiao Hospital, Third Military Medical University.
MtDNA haplogrouping
Genomic DNA was extracted from whole blood using the
QIAamp DNA Blood Mini Kit according to the manufacturer’s
instructions (QIAGEN, Maryland, USA). MtDNA haplogrouping
was completed as described by Li [27]. Briefly, the entire mtDNA
sample was amplified into 22 overlapping PCR fragments and
then digested with 14 restriction endonucleases [28,29]. A negative
control was included in each PCR-restriction fragment length
polymorphism (PCR-RFLP) analysis for mtDNA haplogrouping to
avoid artificial contamination caused by potential sample
crossover. PCR-RFLP analysis was supplemented by sequencing
the hypervariable segment I (HVS-I, from positions 16,024 to
16,383, relative to the revised Cambridge Reference Sequence of
mtDNA, rCRS) [30]. Additionally, selected mtDNAs representing
the major lineages (including haplogroups A, B, D, F, G, M7, and
M8) were completely sequenced. The mtDNA haplotypes, based
on the PCR-RFLPs and HVSI sequences, were classified into
haplogroups according to the phylogenetic analyses of mtDNAs
and Mitomap-Phylogeny [31–36].
Detection of an 822 bp deletion in mtDNA
The primers used for detection of an 822 bp mtDNA deletion
were the following: mtDNA-1 (Forward): 59-TTCGCCTACA-
CAATTCTCCG-39 and mtDNA-2 (reverse): 59-ACAGA-
TACTGCGACATAGGG-39. PCR amplifications were per-
formed in a total volume of 25 mL containing 200 mmol/L of
each dNTP, 0.35 mmol/L of each of the forward and reverse
primers, 50 mmol/L KCl, 10 mmol/L Tris-HCl (pH 9.0),
1.5 mmol/L MgCl2, and 1 U of Taq DNA polymerase (Promega,
Shanghai, China). Cycling conditions included a single pre-
denaturation step at 94uC for 4 min, followed by 39 cycles of
denaturation at 94uC for 40 s, annealing at 59uC for 30 s,
elongation at 72uC for 1 min, and a final incubation at 72uC for
10 min. The PCR products were visualized using electrophoresis
on 1.5% agarose gels stained with ethidium bromide. Five bands
containing the deletion selected randomly were cut from agarose
gels and DNA was purified using a DNA Gel Extraction Kit
(GENERAY, Shanghai, China). Then the purified DNA was
cloned into the pMDH18-T vector according to the manufacturer’s
instructions (TaKaRa, Dalian, China). Twenty clones were
randomly selected for subsequent sequencing. The locations of
the deletion(s) boundaries were determined by alignment of the
PCR product sequence with the rCRS of mtDNA [30]. In order to
detect extremely low levels of the mtDNA deletion, a nested-PCR
method was applied. Primers mtDNA-1 and mtDNA-2 were used
for the primary PCR reaction. 1 ml of the primary PCR products
was then used as a template for the secondary reaction using
primers mtDNA-1 and mtDNA-3 (Reverse: 59- GGCTTTAT-
GACCCTGAAGTAG-39). The PCR conditions for the secondary
reactions were similar to those described for the primary PCR.
The PCR products were visualized using electrophoresis on 2.0%
agarose gels stained with ethidium bromide.
Data analyses
Cigarette smoking was stratified by the median number of pack-
years of combined cases and controls (1 pack-year=20 cigarettes
per day for 1 year). Cases and controls were compared by
Student’s t-test for continuous variables and Pearson’s chi-square
test or Fisher’s exact test for categorical variables. For multiple
comparisons of mtDNA haplogroups, the Bonferroni correction
was used (required significance level=0.05 per number of
comparisons). To assess the independent effect of each mtDNA
haplogroup, multivariate logistic regression analyses, with adjust-
ments for possible confounding factors (age, gender and smoking
habits), were performed to calculate adjusted odds ratios (ORs)
and 95% confidence intervals (95% CI). Assessment of the
association between mtDNA deletion and cigarette smoking was
performed using a linear-by-linear association test after stratifica-
tion based on cigarette consumption. All statistical analyses were
performed using the Statistical Package for Social Science 15 for
Windows (SPSS Inc, Chicago, IL, USA).
Results
Subject characteristics
In total, 442 unrelated patients and 504 unrelated controls were
recruited from southwestern China for the study. No female
cigarette smokers were gathered. The descriptive characteristics of
the study population were given in Table 1. The median number
of pack-years of combined cases and controls was utilized as the
cut-point to stratify the cigarette smoking subjects. As shown in
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follows: adenocarcinoma, 37.33%; squamous cell carcinoma,
26.02%; other non-small cell carcinoma, 22.4%; and small cell
carcinoma, 14.25%. As expected, cases smoked more cigarettes
(p,0.001).
MtDNA haplogrouping
The mtDNA haplogrouping was completed for all cases and
controls. All subjects were classified into 17 common Asian
mtDNA haplogroups by PCR-RFLPs analyses and HVS I
sequencing. The distribution of mtDNA haplogroups in both
cases and controls was shown in Table 2. Pearson’s chi-square test
or Fisher’s exact test revealed that, compared with controls,
mtDNA haplogroups G, M7 and M8 (M8a+C+Z) were signifi-
cantly higher and haplogroups D and F significantly lower among
cases (p,0.001, p=0.001, p=0.003, p,0.001, and p=0.001,
respectively). When the Bonferroni correction was applied
(required significance level=0.05 per number of comparisons),
haplogroup M8 could not reach the adjusted p value cutoff of
,0.0029. Multivariate logistic regression analyses with adjust-
ments for age, gender, and smoking revealed that, on the basis of a
p value of ,0.05, haplogroups D and F were associated with
individuals’ lung cancer resistance (OR=0.465, 95% CI=0.329–
0.656, p,0.001; and OR=0.622, 95% CI=0.425–0.909,
p=0.014, respectively), while haplogroups G and M7 might be
risk factors for lung cancer (OR=3.924, 95% CI=1.757–6.689,
p,0.001; and OR=2.037, 95% CI=1.253–3.312, p=0.004,
respectively).
Detection of the small deletion in mtDNA
Primers mtDNA-1 and mtDNA-2 were primarily used to detect
the deletion of mtDNA. In the wide type mtDNA, the primers only
yielded a product with 1129 bp. In subjects with the mtDNA
deletion, the primers amplified products with 1129 bp and an
aberrant product about 300 bp (Fig. 1A). DNA fragments purified
from five randomly selected bands containing the deletion were
cloned into pMDH18-T vector and sequenced. Sequencing data
revealed that the deleted portion of mtDNA fragment was
approximately 822 bp, starting between 15587–15591 nucleotide
positions (nps) and ending between 16408–16412 nps (Fig. 1C).
Because both ends of the deleted region have the 5 bp same
nucleotides (CTCCG, 5 bp short direct repeats), the exact start
and end points of the deletion could not be determined. In order
to detect extremely low levels of the mtDNA deletion, a nested-
PCR method was applied for all of the cases and controls. In the
wide type mtDNA, the primers mtDNA-1 and mtDNA-3 only
yielded a product with 956 bp. In subjects with the mtDNA
deletion, the primers amplified products with 956 bp and an
aberrant product with 134 bp (Fig. 1B).
Distribution of the 822 bp mtDNA deletion among cases
and controls
When the subjects from both cases and controls were pooled
and stratified by median number of pack-years of combined cases
and controls, a subsequent linear-by-linear association test
revealed an increasing trend for mtDNA deletion from non-
smoking to heavy smoking groups (both p value and p trend
Table 1. Characteristics of the study population.
Characteristic Controls (n=504) (%) Cases (n=442) (%) p-Value
Sex
Male 392 (77.78) 358 (81.00) 0.223
a
Female 112 (22.22) 84 (19.00)
Age at diagnosis (years)
,39 31 (6.15) 24 (5.43) 0.599
a
40–49 87 (17.26) 65 (14.71)
50–59 162 (32.14) 146 (33.03)
60–69 131 (25.99) 132 (29.86)
.70 93 (18.45) 75 (16.97)
Mean age 6 SD 58.43610.52 58.78611.18 0.622
b
Histology
Adenocarcinoma - 165 (37.33) -
Squamous cell carcinoma - 115 (26.02)
Other non-small cell carcinoma - 99 (22.40)
Small cell carcinoma - 63 (14.25)
Pack-years of smoking
c
0–30 447 (88.69) 255 (57.69) ,0.001
a
.30 57 (11.31) 187 (42.31)
Mean pack-year 6 SD 8.63618.43 23.95621.90 ,0.001
b
Mean pack-year 6 SD
d 11.10620.23 29.39620.71 ,0.001
b
ax
2-Test or Fisher’s exact test.
bt-Test.
cThe median number of pack years of combined cases and controls were utilized as the cut-point.
drestricted to males only.
doi:10.1371/journal.pone.0031322.t001
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mtDNA haplogroups Controls (n=504) (%) Cases (n=442) (%) p value (X
2) Adjusted p value
a OR (95% CI)
a
A 36 (7.14%) 38 (8.6%) 0.406 0.294 1.309 (0.791–2.167)
B 96 (19.05%) 89 (20.14%) 0.674 0.836 1.037 (0.734–1.466)
F 104 (20.63%) 55 (12.44%) 0.001 0.014 0.622 (0.425–0.909)
D 140 (27.78%) 74 (16.74%) 0.000 0.000 0.465 (0.329–0.656)
G 14 (2.78%) 35 (7.92%) 0.000 0.000 3.924 (1.757–6.689)
M7 31 (5.95%) 56 (12.67%) 0.001 0.004 2.037 (1.253–3.312)
M8(M8a+C+Z) 31 (5.95%) 51 (11.76%) 0.003 0.109 1.511 (0.912–2.505)
M9 14 (2.78%) 5 (1.13%) 0.072 0.301 0.574 (0.200–1.674)
Y1 2 (0.4%) 6 (1.36%) 0.107 0.351 2.238 (0.412–12.172)
N9a 6 (1.19%) 7 (1.58%) 0.604 0.122 2.391 (0.792–7.219)
R3 6 (1.19%) 3 (0.68%) 0.419 0.675 0.737 (0.177–3.069)
M2 4 (0.79%) 5 (1.13%) 0.594 0.779 1.222 (0.303–4.923)
M10 6 (1.19%) 5 (1.13%) 0.932 0.585 1.408 (0.412–4.812)
M13a 5 (0.99%) 6 (1.36%) 0.601 0.420 1.655 (0.487–5.627)
M11 2 (0.4%) 0 (0%) NA NA NA
M 2 (0.4%) 2 (0.45%) 1.000 0.466 2.080 (0.291–14.877)
U1 5 (0.99%) 5 (1.13%) 0.932 0.822 1.162 (0.313–4.310)
x
2-Test or Fisher’s exact test. Bonferroni corrected p,0.05/n (n=17).
a, ORs (95% CIs) and p value determined by multivariate logistic regression analysis, adjusted for age, gender, and pack-years of cigarette smoking.
doi:10.1371/journal.pone.0031322.t002
Figure 1. Electrophoresis for the detection of the 822 bp mtDNA deletion and the 822 bp mtDNA deletion in the schematic
representation of a linearized mitochondrial genome. (A) PCR products amplified with primers mtDNA-1 and mtDNA-2. The right lane is
molecular marker DL 2000. W1, W2, and W3 showing PCR products with 1129 bp from wide type mtDNA, M1, M2, M3 and M4 indicating PCR
products with 1129 bp and 307 bp from mutant mtDNA. (B) PCR products amplified with primers mtDNA-1 and mtDNA-3. The right lane is molecular
marker DL 2000. W1 and W2 showing PCR products with 956 bp from wide type mtDNA, M1, M2, M3 and M4 indicating PCR products with 956 bp
and 134 bp from mutant mtDNA. (C) The 822 bp mtDNA deletion in the schematic representation of a linearized mitochondrial genome.
Mitochondrial nucleotides were numbered according to rCRS of mtDNA [30]. Nucleotide repeats at or near the sites of cleavage are bracketed. The
placement of . above the bracket indicates that the exact cleavage site within the nucleotide repeat was unknown. The deleted mtDNA fragment
covered from 15587–15591 nps to 16408–16412 nps. CTCCG showed the 5 bp short direct repeats at both ends of the deletion regions. The deletion
was formed by cleavage within the 5 bp direct repeats.
doi:10.1371/journal.pone.0031322.g001
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light-smoking and heavy-smoking subjects pooled from cases and
controls and stratified by smoking habits were compared and given
in Fig. 2B. Pearson’s chi-square test or Fisher’s exact test revealed
that the deletion occurred significantly more frequently in heavy
smoking subjects (p,0.001). Multivariate logistic regression
analyses adjusted for age and gender revealed that cigarette
smoking might be a risk factor for the mtDNA deletion
(OR=6.540, 95% CI=3.247–13.174, adjusted p,0.001). Addi-
tionally, compared with controls, the mtDNA deletion was
significantly enriched in cases of lung cancer (p,0.001) (Fig. 2C).
Multivariate logistic regression analyses with adjustment for age,
gender, and smoking habits revealed that the risk of lung cancer
cases for the mtDNA deletion was 3.8 times higher than that of
controls (OR=3.776, 95% CI=2.662–5.355, adjusted p,0.001).
Interestingly, the occurrence of mtDNA deletion was significantly
higher in female non-smoking subjects than that in male non-
smoking subjects of combined cases and controls (p,0.001)
(Fig. 2D). Multivariate logistic regression analyses adjusted for
age revealed that the risk of female non-smoking subjects for the
mtDNA deletion was 5.8 times higher than that of male non-
smoking subjects (OR=5.814, 95% CI=3.279–10.309, adjusted
p,0.001).
Distribution of the 822 bp mtDNA deletion in major
mtDNA haplogroups of combined cases and controls
The frequencies of mtDNA deletion in major mtDNA
haplogroups of combined cases and controls were given in
Table 3. As shown in Table 3, Pearson’s chi-square test or
Fisher’s exact test revealed that the deletion occurred significantly
more frequently in subjects with mtDNA haplogroups D
(p,0.001). Multivariate logistic regression analyses adjusted for
age, gender and smoking habits revealed that haplogroup D might
be a risk factor for the 822 bp mtDNA deletion (OR=1.906, 95%
CI=1.359–2.738, adjusted p,0.001). The frequencies of mtDNA
deletion in major mtDNA haplogroups among male cigarette
smoking subjects and male non-cigarette smoking subjects of
combined cases and controls were presented in Table 4 and 5,
respectively. As given in Table 4, haplogroup D was found to be a
risk factor for the mtDNA deletion among male cigarette smoking
Figure 2. Distribution of the 822 bp mtDNA deletion among cases and controls. Del, deletion. The median number of pack-years of
combined cases and controls was utilized as the cut-point to stratify the cigarette smoking subjects. The single bar depicting the proportion of
individuals who had the deletion or not. * indicating p,0.001. (A) Distribution of the mtDNA deletion among subjects pooled from cases and controls
and stratified by pack-years of cigarette smoking. Non-smokers who had no any history of cigarette smoking; Light-smokers who smoked 1–30 pack-
years of smoking; Heavy-smokers who smoked .30 pack-years of smoking; p trend was calculated by the chi-square test for linear-by-linear
association (both p value and p trend ,0.001). (B) Distribution of the mtDNA deletion among light-cigarette and heavy-cigarette smoking subjects of
combined cases and controls. Light-smokers who smoked 0–30 pack-years of smoking; Heavy-smokers who smoked .30 pack-years of smoking. ORs
(95% CIs) and p value determined by multivariate logistic regression analysis, adjusted for age and gender (OR=6.540, 95% CI=3.247–13.174,
adjusted p value,0.001). (C) Distribution of the mtDNA deletion among cases and controls. Compared with controls, the mtDNA deletion was
significantly enriched in cases of lung cancer (p,0.001). ORs (95% CIs) and p value determined by multivariate logistic regression analysis with
adjustment for age, gender and smoking habits (OR=3.776, 95% CI=2.662–5.355, adjusted p,0.001). (D) Distribution of the mtDNA deletion among
non-cigarette smoking subjects pooled from cases and controls and stratified by gender. Non-smokers who had no any history of cigarette smoking.
ORs (95% CIs) and p value determined by multivariate logistic regression analysis adjusted for age (OR=5.814, 95% CI=3.279–10.309, adjusted
p,0.001).
doi:10.1371/journal.pone.0031322.g002
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As shown in Table 5, the deletion was enriched in subjects with
mtDNA haplogroups G among male non-cigarette smoking
subjects (p=0.036). Multivariate logistic regression analyses
adjusted for age revealed that on the basis of a p value of
,0.05, haplogroups G might be a risk factor for the mtDNA
deletion in male non-cigarette smoking subjects of combined cases
and controls (OR=3.906, 95% CI=1.381–12.255, adjusted
p=0.017).
Discussion
In the present study, mtDNA haplogroups D and F were found
to be beneficial for individuals’ resistance to lung cancer, whereas
haplogroups G and M7 were associated with an increased risk for
lung cancer in a Han Chinese population from southwestern
China. In addition, cigarette smoking was a risk factor for the
822 bp mtDNA deletion and mtDNA haplogroups D was
susceptible to damage from external ROS caused by cigarette
smoking. The findings provided evidences from the point of
mtDNA that the gene-environment interaction does exist in the
individual susceptibility to lung cancer. To our knowledge, this is
the first study to report the association of lung cancer risk with the
mtDNA variations and of the cigarette smoking with the 822 bp
mtDNA deletion that begins between 15587–15591 nps and ends
between 16408–16412 nps.
The 822 bp mtDNA deletion was accidentally found to be
present in many samples when the primers mtDNA-1 and
mtDNA-2 were used to amplify the mtDNA fragment for
subsequent sequencing of HVS I in the study. In principle, by
using the nested-PCR protocol, it is possible to concentrate deleted
molecules at the first PCR step and detect single molecules. Thus,
all samples (cases and controls) were then re-amplified using the
more sensitive nested-PCR method to detect extremely low levels
of the mtDNA deletion. To investigate the role of the mtDNA
deletion in the study population, the frequencies of mtDNA
deletion were compared between light cigarette smoking subjects
and heavy cigarette smoking subjects of combined cases and
controls. The comparison revealed that the mtDNA deletion was
significantly more frequent in heavy smoking subjects compared
with light smoking subjects. Multivariate logistic regression
analysis revealed that cigarette smoking was a risk factor for the
mtDNA deletion. Many of the substances in cigarette smoke are
chemicals that may create ROS within human body to introduce
oxidative stress which was thought to be involved in lung
carcinogenesis [37,38] and mtDNA mutations [39–41]. Recently,
Table 3. Distribution of the 822 bp mtDNA deletion in major mtDNA haplogroups among subjects pooled from cases and
controls.
MtDNA haplogroups Del (n=206) (%) Non-Del (n=740) (%) p value (X
2) Adjusted p value
a OR (95% CI)
a
A (n=74) 15 (7.28) 59 (7.97) 0.883 0.967 0.987 (0.543–1.795)
B (n=185) 35 (16.99) 150 (20.27) 0.322 0.302 0.805 (0.534–1.215)
M8 (n=82) 15 (7.28) 67 (9.05) 0.486 0.295 0.729 (0.404–1.317)
G (n=49) 11 (5.34) 38 (5.14) 0.860 0.861 1.065 (0.528–2.148)
F (n=159) 41 (19.90) 118 (15.95) 0.206 0.090 1.416 (0.941–2.096)
D (n=214) 65 (31.55) 149 (20.14) ,0.001 ,0.001 1.906 (1.359–2.738)
M7 (n=87) 16 (7.77) 71 (9.59) 0.496 0.189 0.677 (0.380–1.210)
Others (n=96) 8 (3.88) 88 (11.89) NA NA NA
x
2-Test or Fisher’s exact test.
For multiple comparisons, p value was set ,0.05/26(n21) (n=8).
a, ORs (95% CIs) and p value determined by multivariate logistic regression analysis, adjusted for age, gender and pack-years of smoking.
doi:10.1371/journal.pone.0031322.t003
Table 4. Distribution of the 822 bp deletion of mtDNA in major mtDNA haplogroups among male cigarette smoking subjects
pooled from cases and controls
a.
MtDNA haplogroups Del (n=138) (%) Non-Del (n=290) (%) p value (X
2) Adjusted p value
b OR (95% CI)
b
A (n=35) 8 (5.80) 27 (9.31) 0.215 0.243 0.613(0.270–1.394)
B (n=83) 25 (18.12) 58 (20.00) 0.645 0.519 0.842(0.498–1.422)
M8 (n=38) 9 (6.52) 29 (10.00) 0.237 0.304 0.662(0.301–1.454)
G (n=31) 8 (5.80) 23 (7.93) 0.426 0.551 0.774(0.334–1.794)
F (n=65) 27 (19.57) 38 (13.10) 0.082 0.066 1.672(0.967–2.889)
D (n=90) 46 (33.33) 44 (15.17) ,0.001 ,0.001 2.752(1.699–4.456)
M7 (n=52) 12 (8.70) 40 (13.79) 0.131 0.132 0.592(0.299–1.171)
Others (n=34) 3 (2.17) 31 (10.69) NA NA NA
Del, deletion.
For multiple comparisons, P value was set ,0.05/26(n21) (n=8).
a, Cigarette smoking subjects who had any history of cigarette smoking.
b, ORs (95% CIs) and p value determined by multivariate logistic regression analysis adjusted for age.
doi:10.1371/journal.pone.0031322.t004
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associated with future development of lung cancer among heavy
smokers for compensation for damage due to limited DNA repair
capacity of mitochondrial [26]. Thus, the prior findings that heavy
cigarette smokers would have higher internal doses of ROS
[42,43] and increased mtDNA copy number [26] than lighter
cigarette smokers supported our findings that heavy smokers
would have increased frequencies of the mtDNA deletion
compared with light cigarette smokers.
MtDNA deletions are generally believed to be the results of
oxyradical-induced DNA damage, but the mechanism of deletion
is poorly understood. Most mtDNA deletions are predominantly
(,85%) flanked by short direct repeats [44,45]. Presently, there
are two proposals about the formation of mtDNA deletions. One
proposal is that mtDNA deletion could be generated through a
slipped-stand replication mechanism [46]. But the proposal was
challenged by the recent modification of the strand-displacement
model which argues that large regions of single-stranded DNA do
not exist, rather, the lagging-strand template is largely protected
by RNA [47,48]. Another proposal is that mtDNA deletions could
be generated during repair of damaged DNA caused by increased
oxidative stress from whatever causes [49]. The later proposal was
supported by many evidences from E. coli, mice to human cells
[50–53]. The 822 bp mtDNA deletion detected in the study is also
flanked by 5 bp short direct repeats (CTCCG) (Fig. 1C). Our
findings provided indirect evidence to support the later proposal
that the mtDNA deletions could be created during repair of
damaged DNA generated by cigarette smoking. Understanding
the mechanism involved in generation and subsequent clonal
expansion is worthwhile to investigate further.
Compared with controls, the mtDNA deletion was found to be
enriched in cases. In order to investigate whether the mtDNA
deletion was associated with some mtDNA haplogroups, the
frequencies of the mtDNA deletion in major mtDNA haplogroups
of combined cases and controls were analyzed and the data
revealed that the deletion occurred significantly more frequently in
mtDNA haplogroups D and multivariate logistic regression
analyses revealed that haplogroup D might be a risk factor for
the mtDNA deletion. Since the cigarette smoking was a risk factor
for the mtDNA deletion and no female cigarette smoking subjects
were gathered in the study, the male subjects pooled from cases
and controls were stratified by cigarette smoking into male
cigarette smoking subjects and male non-cigarette smoking
subjects to analyze further the association of mtDNA deletion
with mtDNA haplogroups. The analysis of the frequencies of the
mtDNA deletion in major mtDNA haplogroups among male
cigarette smoking subjects also revealed that haplogroup D might
be risk factors for the mtDNA deletion. No similar significant
difference was found among male non-cigarette smoking subjects.
However, mtDNA haplogroup G was found to be a risk factor for
the deletion among male non-cigarette smoking subjects. Inter-
estingly, the deletion was enriched in female non-cigarette smoking
subjects compared with male non-cigarette smoking subjects of
combined cases and control. One reason we hypothesized to
explain this difference is that cooking oil fumes could be a greater
risk factor for the mtDNA deletion for females who cook far more
often than men in southwestern China.
Several mtDNA haplogroups were found to play roles in human
longevity, carcinogenesis, Leber’s hereditary optic neuropathy
(LHON), and other metabolic and degenerative diseases. MtDNA
haplogroup D is one of these mtDNA haplogroups. Haplogroup D
is defined by the specific variation C5178A in mitochondrial
NADH dehydrogenase subunit 2 (ND2). Prior studies showed that
the protective effect of a LeuRMet substitution at amino acid 237
(L237M) of ND2 (C5178A) against oxidative damage to
mitochondria not only contributes to human longevity [13,16],
but also provides strong anti-atherosclerotic effects in diabetic
patients and protects against myocardial infarction [14]. Thus, the
protective effect of haplogroup D against oxidative damage might
also decrease the risk of lung cancer. The frequency of haplogroup
J, which was found to be correlated with lower efficiency of the
electron transport chain (ETC), diminished ATP, diminished ROS
production, and accumulation in elderly people, was increased in
patients with LHON and multiple sclerosis due to its limited power
to compensate the mitochondrial energetic deficiency [18,19].
Similarly, haplogroup D could account for the increased frequency
of the C5178A variant in elderly people, which is caused by
decreased oxidative damage [13,16]. However, once the external
ROS created by cigarette smoking increases, the frequency of the
mtDNA deletion increases in cigarette-smoking subjects with
haplogroup D. One reason we hypothesized to explain the
phenomena that the mtDNA haplogroup D was found to be
protective in lung cancer while the mtDNA deletion was enriched
in male cigarette-smoking subjects with mtDNA haplogroup D of
combined cases and controls is that individuals with haplogroup D
might be susceptible to damage of external ROS caused by
Table 5. Distribution of the 822 bp deletion of mtDNA in major mtDNA haplogroups among male non-cigarette smoking subjects
pooled from cases and controls
a.
MtDNA haplogroups Del (n=18) (%) Non-Del (n=304) (%) p value (X
2) Adjusted p value
b OR (95% CI)
b
A (n=30) 2 (11.11) 28 (9.21) 0.679 0.677 1.398 (0.290–6.736)
B (n=61) 3 (16.67) 58 (19.08) 1.000 0.819 0.861 (0.239–3.106)
M8 (n=24) 2 (11.11) 22 (7.24) 0.634 0.634 1.457 (0.309–6.870)
G (n=14) 3 (16.67) 11 (3.62) 0.036 0.017 3.906 (1.381–12.255)
F (n=61) 3 (16.67) 58 (19.08) 1.000 0.790 0.839 (0.230–3.055)
D (n=72) 3 (16.67) 69 (22.70) 0.772 0.625 0.726 (0.202–2.613)
M7 (n=18) 1 (5.56) 17 (5.59) 1.000 0.950 1.069 (0.132–8.626)
Others (n=42) 1 (5.56) 41 (13.49) NA NA NA
Del, deletion.
For multiple comparisons, p value was set ,0.05/26(n21) (n=8).
a, non-cigarette smoking subjects who had no any history of cigarette smoking.
b, ORs (95% CIs) and p value determined by multivariate logistic regression analysis adjusted for age.
doi:10.1371/journal.pone.0031322.t005
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constitute an important anti-oxidant defense mechanism [54].
According to the predicted model of human ND2 molecular [55],
the LeuRMet substitution at amino acid 237 (L237M) of ND2
(C5178A) is exposed at the surface of complex I and may play
important roles in protective effect against oxidative damage to
mitochondria as an efficient oxidant scavenger [13]. Localization
of the methionine residue (LeuRMet) on the surface of the
complex I might also be a target for damage of increased ROS
whatever caused. The damaged residue or surface structure of the
complex I might cause or exacerbate the deletion of mtDNA. The
other reason we supposed to explain the phenomena is that the
lung cancer risk and the mtDNA deletion were not influenced
solely by the mtDNA variations. The nuclear background in which
the mtDNA haplogroups are classified and the mtDNA deletion
was found may also contribute to the individuals’ susceptibility to
lung cancer risk and the mtDNA deletion. Investigating the
generation of endogenous ROS and the protective effect against
oxidative damage to mitochondria under different conditions of
different mtDNA haplogroups with the same nuclear background,
or investigating the different nuclear background with the same
mtDNA haplogroups, may help us, at least in part, to explore the
fundamental mechanisms.
Haplogroup F was also identified less often in lung cancer cases
as haplogroup D, but no significant difference was found in the
frequencies of the mtDNA deletion among male cigarette-smoking
subjects with haplogroup F. Haplogroup F has been divided into
sub-haplogroups F1–4 in East Asia [35]. We speculate that
haplogroup F might confer decreased lung cancer risk through
some antioxidant defense mechanism. It is worthwhile to
investigate further the role of haplogroup F in lung cancer
resistance.
Both haplogroups M7 and G were found to be risk factors for
lung cancer in this study. Haplogroup M7 was defined by a
specific variation at np T9824C [34] and Haplogroup G was
classified with the presence of the combined RFLP-4830 HaeII
site/+4831 HhaI site [56]. Previous studies have demonstrated that
M7b1’2, a sub-haplogroup of M7, was found to increase the
penetrance of LHON [57] and haplogroup M7 was a risk factor
for mild acute mountain sickness (AMS) [27]. In the present study,
haplogroups G and M7 were found to be present in controls at
frequencies of 2.78% and 5.95%, respectively, but were present in
cases of lung cancer at frequencies of 7.92% and 12.67%,
respectively. The findings that no significant difference was
observed in the frequencies of the mtDNA deletion in male
cigarette smoking subjects with haplogroup M7 or G indicated
that the two haplogroups might better tolerate the damage of
external ROS caused by cigarette smoking due to their relatively
higher endogenous ROS production, which was supported by the
subsequent finding that the frequencies of the mtDNA deletion
increased in male non-cigarette smoking subjects with haplogroup
G.
Though we conducted a population-based case-control study,
there were several limitations. First, due to limited cases, we did
not analyze the distribution of the mtDNA haplogroups or the
mtDNA deletion in each type of lung cancer to investigate whether
the risk of a certain type of lung cancer was associated with one or
more mtDNA haplogroups or with the mtDNA deletion. Second,
because the distribution of mtDNA haplogroups varies spatially in
China, large-scale studies are required to clarify the association of
mtDNA variation with lung cancer risk in other populations.
In summary, we conducted a case-control study to investigate
the role of mtDNA variations in individual risk of lung cancer in a
Han Chinese population from southwestern China. Our findings
suggested that mtDNA haplogroups G and M7 might be risk
factors for lung cancer, whereas haplogroups D and F might
decrease the risk of lung cancer in the study population. In
addition, the study revealed that mtDNA haplogroup D might be
relatively more susceptible to DNA damage from the external
ROS caused by cumulative cigarette smoking. And the 822 bp
mtDNA deletion, which was positively associated with cigarette
smoking, would be a potential biomarker for the exogenous and
endogenous exposures that are associated with subsequent
cigarette-smoking-related diseases.
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